相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
Sarah K. Orr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Dissecting the contribution of knee joint NGF to spinal nociceptive sensitization in a model of OA pain in the rat
D. R. Sagar et al.
OSTEOARTHRITIS AND CARTILAGE (2015)
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
Magnus Back et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
ASPIRIN-TRIGGERED LIPOXIN A4 ATTENUATES MECHANICAL ALLODYNIA IN ASSOCIATION WITH INHIBITING SPINAL JAK2/STAT3 SIGNALING IN NEUROPATHIC PAIN IN RATS
Z. -F. Wang et al.
NEUROSCIENCE (2014)
Synaptic plasticity in pathological pain
Ceng Luo et al.
TRENDS IN NEUROSCIENCES (2014)
Pathological pain and the neuroimmune interface
Peter M. Grace et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Resolvin E1 Inhibits Neuropathic Pain and Spinal Cord Microglial Activation Following Peripheral Nerve Injury
Zhen-Zhong Xu et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Spinal Actions of Lipoxin A4 and 17(R)-Resolvin D1 Attenuate Inflammation-Induced Mechanical Hypersensitivity and Spinal TNF Release
Sally Abdelmoaty et al.
PLOS ONE (2013)
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system
Bright N. Okine et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research
C. Kilkenny et al.
OSTEOARTHRITIS AND CARTILAGE (2012)
Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors
Ann M. Gregus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation
Antonio Recchiuti et al.
FRONTIERS IN IMMUNOLOGY (2012)
The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats
J. F. Lima-Garcia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Resolvins and Protectins in Inflammation Resolution
Charles N. Serhan et al.
CHEMICAL REVIEWS (2011)
Resolvin D2 Is a Potent Endogenous Inhibitor for Transient Receptor Potential Subtype V1/A1, Inflammatory Pain, and Spinal Cord Synaptic Plasticity in Mice: Distinct Roles of Resolvin D1, D2, and E1
Chul-Kyu Park et al.
JOURNAL OF NEUROSCIENCE (2011)
The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain
Devi Rani Sagar et al.
MOLECULAR PAIN (2011)
Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1
Liang Huang et al.
PAIN (2011)
Tonic Modulation of Spinal Hyperexcitability by the Endocannabinoid Receptor System in a Rat Model of Osteoarthritis Pain
Devi Rani Sagar et al.
ARTHRITIS AND RHEUMATISM (2010)
Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids
L. E. Staniaszek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions
Zhen-Zhong Xu et al.
NATURE MEDICINE (2010)
Sensitization in patients with painful knee osteoarthritis
Lars Arendt-Nielsen et al.
PAIN (2010)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain
Maulik D. Jhaveri et al.
NEUROPHARMACOLOGY (2008)
Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor
Anna-Lena Stenfeldt et al.
INFLAMMATION (2007)
Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat
Aml Erhuma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Resolvin D1 and its aspirin-triggered 17R epimer -: Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation
Yee-Ping Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions
Makoto Arita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo
Nan Chiang et al.
PHARMACOLOGICAL REVIEWS (2006)
Development and pharmacological characterization of a rat model of osteoarthritis pain
JD Pomonis et al.
PAIN (2005)
Molecular circuits of resolution: Formation and actions of resolvins and protectins
GL Bannenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Involvement of spinal lipoxygenase metabolites in hyperalgesia and opioid tolerance
T Trang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing
CI Svensson et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
分享论文
